ArticleBMC cancer2025
Comparison of double-layered scallop-shaped anastomosis and circular stapled anastomosis in Ivor-Lewis surgery for esophageal and EGJ cancer: a retrospective cohort study.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundCancers of the lower esophagus and esophagogastric junction (EGJ) are highly aggressive and have poor prognoses. Minimally invasive Ivor-Lewis surgery (MIIL) is the preferred treatment, but anastomotic leakage (AL) remains a critical complication of this procedure. In the present study, we introduce a novel double-layered scallop-shaped anastomosis (DLSSA) technique and compare its outcomes with those of circular stapled esophagogastric anastomosis (CSEA).
methodsFrom April 2016 to February 2023, 117 patients with distal esophageal or EGJ cancer who underwent complete thoracoscopic-laparoscopic Ivor-Lewis surgery were retrospectively analyzed. Patients were divided into DLSSA (n = 50) and CSEA (n = 67) groups. The median value and ranges are used to present the numerical data. Continuous and categorical variables were compared between groups with the Kruskal‒Wallis test and Fisher's exact test or χ2 test, respectively. Multivariable binary logistic regression analyses were performed to identify potential prognostic factors.
resultsThe median total operation duration was similar between the groups (280 min). Intraoperative blood loss was slightly greater in the CSEA group (120 ml vs. 100 ml, p = 0.001). Postoperative complications occurred in 32.5% of the patients, with no significant between-group difference. However, the incidence of AL was significantly lower (4.0% vs. 17.9%, p = 0.022) and that of pleural effusion was significantly greater (10.0% vs. 1.5%, p = 0.039) in the DLSSA group than in the CSEA group. Multivariable analysis revealed that a higher body mass index (OR = 1.453, 95% CI: 1.119-1.888; p = 0.005) was a risk factor for AL, whereas undergoing DLSSA was associated with reduced AL risk (OR = 0.052, 95% CI: 0.005-0.525; p = 0.012), and both variables were considered independent predictors of AL risk.
conclusionCompared with CSEA, DLSSA was associated with significantly lower risk of AL in thoracoscopic Ivor-Lewis surgery, demonstrating its potential as a safer anastomotic technique. However, its association with increased pleural effusion warrants further investigation. Prospective randomized trials are needed to validate long-term outcomes and optimize procedural efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.